Allmed Medical Products Co., Ltd (002950.SZ)
CNY 8.87
(-0.11%)
CNY 8.87
(-0.11%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 426.3 Million | 1.14 Billion | 374.85 Million | 1.43 Billion | 273.13 Million | 3 Million |
| Net Income | 110.39 Million | 404.64 Million | 431.96 Million | 1.16 Billion | 324.19 Million | 226.31 Million |
| Depreciation & Amortization | 229.86 Million | 193.19 Million | 147.21 Million | 142.22 Million | 121.37 Million | 111.11 Million |
| Deferred income taxes | -50.75 Million | 85.74 Million | 26.68 Million | 56.65 Million | 38.77 Million | -8.66 Million |
| Stock-based compensation | - | -85.74 Million | -26.68 Million | -56.65 Million | -38.77 Million | - |
| Change in working capital | -16.05 Million | 192.56 Million | -152.67 Million | 224.47 Million | -200.15 Million | -370.87 Million |
| Other non-cash items | 628.64 Million | 359.31 Million | -51.64 Million | -90.42 Million | 27.72 Million | 36.45 Million |
| Investing Cash Flow | -218.25 Million | -970.52 Million | -473.11 Million | -744.82 Million | -217.81 Million | -277.99 Million |
| Investments in PPE | -286.48 Million | -398.04 Million | -290.69 Million | -243.28 Million | -232.55 Million | -287.07 Million |
| Acquisitions | 773.69 Thousand | -99.07 Million | -90.82 Million | 329.04 Million | 52.22 Million | 100.00 |
| Investment purchases | -211.53 Million | -1.97 Billion | -2.98 Billion | -3.88 Billion | -115.67 Million | -2.4 Million |
| Sales/Maturities of investments | 350.98 Million | 1.5 Billion | 2.89 Billion | 3.3 Billion | 77.76 Million | 2.75 Million |
| Other Investing Activities | -72 Million | 1.29 Million | -8.18 Million | -243.28 Million | 410.45 Thousand | 8.72 Million |
| Financing Cash Flow | -328.8 Million | -236.4 Million | -552.74 Million | 358.69 Million | -85.94 Million | 392.18 Million |
| Debt repayment | -205.93 Million | -2.97 Billion | -3.18 Billion | -914.51 Million | -1.52 Billion | -1.32 Billion |
| Dividends payments | -37.99 Million | -132.98 Million | -557.27 Million | -253.3 Million | -63.32 Million | -35.14 Million |
| Common Stock Repurchased | - | - | - | - | 9.16 Million | - |
| Common Stock Issuance | - | - | - | - | -9.16 Million | - |
| Other Financing Activities | -82.24 Million | 2.9 Billion | 3.2 Billion | 1.53 Billion | 1.54 Billion | 1.75 Billion |
| Accounts receivables | 157.56 Million | -18.06 Million | 75.81 Million | 64.95 Million | 85.91 Million | -236.31 Million |
| Accounts payables | -244.71 Million | 162.02 Million | -111.75 Million | 84.37 Million | -164.92 Million | 151.69 Million |
| Inventory | 71.08 Million | -37.13 Million | -143.4 Million | 18.49 Million | -159.92 Million | -277.57 Million |
| Other working capital | -295.47 Million | 85.74 Million | 26.68 Million | 56.65 Million | 38.77 Million | -93.29 Million |
| Cash at beginning of period | 522.2 Million | 662.75 Million | 1.3 Billion | 242.52 Million | 270.98 Million | 167.82 Million |
| Cash at end of period | 397.03 Million | 502.91 Million | 662.75 Million | 1.3 Billion | 242.52 Million | 270.98 Million |
| Capital Expenditure | -286.48 Million | -398.04 Million | -290.69 Million | -243.28 Million | -232.55 Million | -287.07 Million |
| Effect of forex changes on cash | 7.55 Million | -102.64 Million | 11.93 Million | 8.7 Million | 2.17 Million | -14.03 Million |
| Net cash flow / Change in cash | -125.16 Million | -159.84 Million | -639.08 Million | 1.05 Billion | -28.45 Million | 103.16 Million |
| Free Cash Flow | 139.82 Million | 751.68 Million | 84.15 Million | 1.19 Billion | 40.58 Million | -284.06 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 78.16 Million | 93.11 Million | 93.87 Million | -40 Million | 110.39 Million | -6.63 Million |
| Depreciation & Amortization | - | 58.05 Million | 58.05 Million | 58.4 Million | 229.86 Million | -111.24 Million |
| Deferred income taxes | - | - | - | - | -50.75 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 46.68 Million | - | 228.65 Million | -16.05 Million | -136.42 Million |
| Other non-cash items | 111.36 Million | 104.73 Million | 93.9 Million | 65.3 Million | 628.64 Million | 506.59 Million |
| Investing Cash Flow | -27.06 Million | -30.45 Million | -39.15 Million | -70.11 Million | -218.25 Million | -76.61 Million |
| Investments in PPE | -37.46 Million | -36.82 Million | -41.37 Million | -91.31 Million | -286.48 Million | -58.46 Million |
| Acquisitions | 9 Million | 612 Thousand | 3450.00 | -7029.77 | 773.69 Thousand | 2400.00 |
| Investment purchases | - | - | -1.27 Million | -51 Million | -211.53 Million | -14 Million |
| Sales/Maturities of investments | 1.39 Million | 5.75 Million | 3.48 Million | 144.2 Million | 350.98 Million | -4.14 Million |
| Other Investing Activities | - | 6.16 Million | 2.21 Million | -72 Million | -72 Million | - |
| Financing Cash Flow | -18.1 Million | -101.47 Million | -82.16 Million | 93.76 Million | -328.8 Million | -155.95 Million |
| Debt repayment | -17.74 Million | -24.07 Million | -78.91 Million | -173.42 Million | -205.93 Million | -306.83 Million |
| Dividends payments | - | -26.67 Million | -4.9 Million | -37.99 Million | -37.99 Million | -6.18 Million |
| Common Stock Repurchased | - | -97.89 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -364.36 Thousand | -125.55 Million | -3.25 Million | -39.03 Million | -82.24 Million | 157.05 Million |
| Accounts receivables | - | -46.71 Million | - | 157.56 Million | 157.56 Million | -153.15 Million |
| Accounts payables | - | - | - | - | -244.71 Million | - |
| Inventory | - | 93.39 Million | - | 71.08 Million | 71.08 Million | 16.72 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 471.32 Million | 461.91 Million | 397.03 Million | 393.94 Million | 522.2 Million | 374.8 Million |
| Cash at end of period | 606.7 Million | 471.32 Million | 461.91 Million | 397.03 Million | 397.03 Million | 393.65 Million |
| Capital Expenditure | -37.46 Million | -36.82 Million | -41.37 Million | -91.31 Million | -286.48 Million | -58.46 Million |
| Effect of forex changes on cash | - | 1.54 Million | 982.07 Thousand | 5.5 Million | 7.55 Million | -878.19 Thousand |
| Net cash flow / Change in cash | 135.37 Million | 9.4 Million | 64.88 Million | 3.08 Million | -125.16 Million | 18.84 Million |
| Free Cash Flow | 152.06 Million | 102.96 Million | 146.4 Million | -124.41 Million | 139.82 Million | 193.82 Million |
XCX
RGA
600569
FREJN
FVI
600083